A VISIONaerie™ approach
We discover, develop, and commercialize first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye
NEWSAerie Pharmaceuticals, Inc. Announces Drug Application for Regulatory... Aerie Pharmaceuticals Reports Topline Result from Rhopressa®... Aerie Pharmaceuticals to Announce Second Quarter 2018 Financial...
Oct 22, 4:00 PM ET
52 - WEEK LOW/HIGH